Surgery and Interventional Radiology Collaborate on Combination Therapy in Hepatocellular Carcinoma hepatocellular carcinoma, Hepatology, 2002;35:1164–71.
35. Bruix J, Sherman M, Llovet JM, et al., Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver, J Hepatol, 2001;35:421–30.
36. Marelli L, Stigliano R, Triantos C, et al., Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies, Cardiovasc Intervent Radiol, 2007;30:6–25.
37. Coldwell DM, Stokes KR, Yakes WF, Embolotherapy: agents, clinical applications, and techniques, Radiographics, 1994;14:623–43.
38. Rand T, Loewe C, Schoder M, et al., Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate, Cardiovasc Intervent Radiol, 2005;28:313–8.
39. Gerunda GE, Neri D, Merenda R, et al., Role of transarterial chemoembolization before liver resection for hepatocarcinoma, Liver Transpl, 2000;6:619–26.
40. Hanjan T, De Sanctis J, Hepatic arterial interventions, In: Ray CE, Hichks ME, Patel NH (eds), SIR Syllabus: Interventions in Oncology, Fairfax, VA: Society of Interventional Radiology, 2003;103–18.
41. Lewis AL, Gonzalez MV, Lloyd AW, et al., DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization, J Vasc Interv Radiol, 2006;17:335–42.
42. Lammer J, Malagari K, Vogl T, et al., Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study, Cardiovasc Intervent Radiol, 2010;33:41–52.
43. Carr BI, Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients, Liver Transpl, 2004;10:S107–10.
44. Kooby DA, Egnatashvili V, Srinivasan S, et al., Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma, J Vasc Interv Radiol, 2010;21:224–30.
45. Salem R, Lewandowski RJ, Mulcahy MF, et al., Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes, Gastroenterology, 2010;138:52–64.
46. Salem R, Lewandowski RJ, Kulik L, et al., Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma, Gastroenterology,
2011;140(2):497–507.e2.
47. Kulik LM, Atassi B, van Holsbeeck L, et al., Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation, J Surg Oncol, 2006;94:572–86.
48. Lewandowski RJ, Kulik LM, Riaz A, et al., A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization, Am J Transplant, 2009;9:1920–8.
49. Ogihara M, Wong LL, Machi J, Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: long-term outcomes, HPB (Oxford), 2005;7:214–21.
50. Rossi S, Garbagnati F, Lencioni R, et al., Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply, Radiology, 2000;217:119–26.
51. Livraghi T, Meloni F, Di Stasi M, et al., Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?, Hepatology, 2008;47:82–9.
52. Lencioni RA, Allgaier HP, Cioni D, et al., Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio- frequency thermal ablation versus percutaneous ethanol injection, Radiology, 2003;228:235–40.
53. Lin SM, Lin CJ, Lin CC, et al., Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm, Gastroenterology, 2004;127:1714–23.
54. Shiina S, Teratani T, Obi S, et al., A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma, Gastroenterology, 2005;129:122–30.
55. Iwatsuki S, Starzl TE, Sheahan DG, et al., Hepatic resection versus transplantation for hepatocellular carcinoma, Ann Surg, 1991;214:221–8.
56. Pichlmayr R, Weimann A, Oldhafer KJ, et al., Appraisal of transplantation for malignant tumours of the liver with special reference to early stage hepatocellular carcinoma, Eur J Surg Oncol, 1998;24:60–7.
57. Imamura H, Matsuyama Y, Tanaka E, et al., Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy, J Hepatol, 2003;38:200–7.
58. Poon RT, Fan ST, Ng IO, et al., Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma, Cancer, 2000;89:500–7. 59. Patt CH, Thuluvath PJ, Role of liver transplantation in the
management of hepatocellular carcinoma, J Vasc Interv Radiol, 2002;13:S205–10.
60. Mazzaferro V, Regalia E, Doci R, et al., Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis, N Engl J Med, 1996;334:693–9.
61. Ismail T, Angrisani L, Gunson BK, et al., Primary hepatic malignancy: the role of liver transplantation, Br J Surg, 1990;77:983–7.
62. Pichlmayr R, Weimann A, Steinhoff G, et al., Liver transplantation for hepatocellular carcinoma: clinical results and future aspects, Cancer Chemother Pharmacol, 1992;31(Suppl.):S157–61.
63. Selby R, Kadry Z, Carr B, et al., Liver transplantation for hepatocellular carcinoma, World J Surg, 1995;19:53–8.
64. Lau WY, Primary liver tumors, Semin Surg Oncol, 2000;19:135–44. 65. Bismuth H, Morino M, Sherlock D, et al., Primary treatment of hepatocellular carcinoma by arterial chemoembolization, Am J Surg, 1992;163:387–94.
66. Penn I, Hepatic transplantation for primary and metastatic cancers of the liver, Surgery, 1991;110:726–34.
67. Klintmalm G, Discussion on: Hepatic transplantation for primary and metastatic cancers of the liver, Surgery, 1991;110:734–5.
68. Busuttil RW, Discussion on: Hepatic resection versus transplantation for hepatocellular carcinoma, Ann Surg, 1991;214:228–9.
69. Goldstein DA, Oda Y, Kurokawa K, et al., Blood levels of 25-hydroxyvitamin D in nephrotic syndrome. Studies in 26 patients, Ann Intern Med, 1977;87:664–7.
70. Beavers KL, Sandler RS, Shrestha R, Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review, Liver Transpl, 2002;8:110–7.
71. Pascher A, Sauer IM, Walter M, et al., Donor evaluation, donor risks, donor outcome, and donor quality of life in adult-to-adult living donor liver transplantation, Liver Transpl, 2002;8:829–37.
72. Kim-Schluger L, Florman SS, Schiano T, et al., Quality of life after lobectomy for adult liver transplantation, Transplantation, 2002;73:1593–7.
73. Sarasin FP, Majno PE, Llovet JM, et al., Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective, Hepatology, 2001;33:1073–9.
74. Bolondi L, Piscaglia F, Camaggi V, et al., Review article: liver transplantation for HCC. Treatment options on the waiting list, Aliment Pharmacol Ther, 2003;17(Suppl. 2):145–50.
US GASTROENTEROLOGY & HEPATOLOGY REVIEW
49
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76